Tango Therapeutics (TNGX, $9.76) was one of top quarterly gainers, jumping +3 to $9.76 per share. A.I.dvisor analyzed 875 stocks in the Biotechnology Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.